Search results
A Multicenter Treatment Protocol of Daclatasvir (BMS-790052) in Combination with Sofosbuvir for the Treatment of Post-Liver Transplant Subjects with Chronic Hepatitis C
… The primary objective of this program is to provide DCV for 24 weeks to be given in combination with SOF to subjects … of Daclatasvir (BMS-790052) in Combination with Sofosbuvir for the Treatment of Post-Liver Transplant Subjects with …
Last Modified:
A Randomized Trial Comparing the ELUVIA™ Drug-eluting Stent Versus Zilver® PTX® Stent for Treatment of Superficial Femoral and/or Proximal Popliteal Arteries
… the ELUVIA™ Drug-eluting Stent Versus Zilver® PTX® Stent for Treatment of Superficial Femoral and/or Proximal …
Last Modified:
The Pancreas Center has collaborated with Roche – Genentech for our most recent clinical trial: MORPHEUS a Phase 1b/2 novel pancreatic cancer immunotherapy development platform.
… Pancreatic Center has collaborated with Roche – Genentech for our most recent clinical trial. Roche-Genetech is a … Also, because this study has the flexibility of creating more treatment regimens throughout the continuation of the … needed to continue developing trustworthy approaches. For example, determining how patients respond to a given …
Last Modified:
A Long Term Follow-up Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Gilead-Sponsored Trials in Subjects with Chronic Hepatitis C Infection
… up study is observational and no treatment is provided for HCV. Trial Website: … A Long Term Follow-up Registry for Subjects Who Achieve a Sustained Virologic Response to …
Last Modified:
Phase I Study of Talimogene Laherparepvec Administered Endoscopically for the Treatment of Locally Advanced or Metastatic Pancreas Cancer Refractory to at Least One Chemotherapy Regimen
… of Talimogene Laherparepvec Administered Endoscopically for the Treatment of Locally Advanced or Metastatic Pancreas …
Last Modified:
THRIVE: Thymira Indeterminate FNA Validation: A Validation study to establish the specificity and sensitivity of Thymira diagnostic test for patients with Indeterminate FNAs versus the standard pathological examination
… study of a new molecular diagnostic test, Thymira, for determining malignancy risk in indeterminate nodules. … the specificity and sensitivity of Thymira diagnostic test for patients with Indeterminate FNAs versus the standard …
Last Modified:
Use of Endoscopically Delivered Radiofrequency Ablation for the Treatment of Patients Who Have Undergone Roux-en-Y Gastric Bypass and Have Failed to Achieve/ Maintain Satisfactory Excess Body Weight Loss
… of radiofrequency ablation, delivered via endoscopy, for the treatment of weight regain or inadequate weight loss … not lose at least 40% of their excess weight are eligible for this study. … Use of Endoscopically Delivered Radiofrequency Ablation for the Treatment of Patients Who Have Undergone Roux-en-Y …
Last Modified:
Prospective Randomized Double Blind Placebo Controlled Trial of Rifaximin 550mg PO Twice Daily for Three Months to Prevent Recurrent Fibrosis in Liver Transplant Recipients with Chronic Hepatitis C Virus Infection
… of a poorly-absorbable antibiotic (rifaximin) for the first three months after liver transplant will reduce … in this study. Subjects will be part of the study for approximately 1 year post transplant. Trial Website: … Placebo Controlled Trial of Rifaximin 550mg PO Twice Daily for Three Months to Prevent Recurrent Fibrosis in Liver …
Last Modified:
An Expanded Access Phase 2 Study of Sofosbuvir with Ribavirin and with or without Pegylated Interferon for 24 weeks in Subjects who have undergone Liver Transplantation and Who Have Aggressive, Recurrent Hepatitis C infection
… specific clinical sites at the request of an investigator for the treatment of individual subjects for whom there are no other treatment options. Subjects will be treated for 24 weeks with sofosbuvir (400mg QD) with RBV; pegylated … with Ribavirin and with or without Pegylated Interferon for 24 weeks in Subjects who have undergone Liver …
Last Modified:
A randomized, parallel-group, double-blind, placebo-controlled, multi-center study of eculizumab for the prevention of delayed graft function after kidney transplantation in adult subjects at increased risk of delayed graft function.
… placebo-controlled, multi-center study of eculizumab for the prevention of delayed graft function after kidney …
Last Modified:
A Randomized, Double-blind, Placebo-controlled, Dose-ranging, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Prevention of Complications in Subjects With Early Decompensated Liver Cirrhosis
… agent, is currently marketed as a 550 mg tablet for the reduction in risk of recurrent overt hepatic … of rifaximin SSD tablets or placebo tablets every day for 24 weeks. Trial Website: … Safety of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Prevention of Complications in Subjects With Early …
Last Modified:
Five Pieces of Advice from a Pancreatic Cancer Survivor
… advanced screening tools, or anything else that medicine can now offer Insist on doctors who will coordinate and … Side Effects : What can one expect from chemo treatment? Prices : If a medication is prescribed, will insurance cover … ALAN’S ADVICE: Specify an Emergency Contact—someone reliable who can be easily reached Consider traveling to …
Last Modified:
What is Gender Affirmation Care? On Treating the Whole Person
… Before we begin, for family members, loved ones, folks who may not yet know, will you define the term Gender … discomfort related to gender. Often physical, but it can also be social, that arises from an incongruence in … that also practice with that model and don't require a letter or any sort of meeting or established …
Last Modified:
State of the Union: The Stealth Innovations of Modern Surgical Care
… has really started to take off in ways that it hadn't for 20 years. And it's not so much that we're doing … they're doing in some labs is building organs. And if they can do that, it could leapfrog xenotransplant by creating … why can't AI train on AI? Right, is a training set reliable if it’s AI-generated? Exactly. How will we know …
Last Modified:
What We're Reading: 11/07/25
… feeds this week. What Trump’s New Drug Pricing Deal Means for People with Obesity Obesity care continues to sit at the … ever, eligibility is complicated; the “sticker price” isn’t the full story, and coverage depends heavily on insurance, … feel sci-fi, it’s hard to ignore models that can debug thousands of lines of code, reason across images …
Last Modified: